Management of Primary Diffuse Large B-cell Lymphoma of The Central Nervous System: Clinical Study

被引:0
作者
Basmaci, Mehmet [1 ]
Hasturk, Askin Esen [1 ]
Ayata, Tulu [1 ]
机构
[1] Dr Abdurrahman Yurtaslan Oncol Training & Res Hos, Ankara, Turkey
来源
JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH | 2013年 / 30卷 / 02期
关键词
Central Nervous System; Immunosuppression; Lymphoma; Treatment; TUMOR;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Primary Central Nervous System Lymphomas (PCNSL) are defined as the extra nodal non-Hodgkin lymphomas which may typically be localized in brain, eyes, spinal cord and CSF without arising from a focus site, and which are uncommon and non - Hodgkin types. The prevalence of PCNSL has been reported to have increased pronouncedly for the last 15 - 30 years. The reason of this increase for the PCNSL among other primary brain tumors is considered to be associated with the improvements in the diagnostic methods. The objective of this study is to assess 9 patients who presented with PCNSL, retrospectively.
引用
收藏
页码:469 / 476
页数:8
相关论文
共 27 条
[1]   Diffusion-Weighted MR Imaging Derived Apparent Diffusion Coefficient Is Predictive of Clinical Outcome in Primary Central Nervous System Lymphoma [J].
Barajas, R. F., Jr. ;
Rubenstein, J. L. ;
Chang, J. S. ;
Hwang, J. ;
Cha, S. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2010, 31 (01) :60-66
[2]  
Bhagavathi S, 2008, ARCH PATHOL LAB MED, V132, P1830, DOI 10.1043/1543-2165-132.11.1830
[3]   Treatment approaches for primary CNS lymphomas [J].
Carrabba, Matteo G. ;
Reni, Michele ;
Foppoli, Marco ;
Chiara, Anna ;
Franzin, Alberto ;
Politi, Letterio Salvatore ;
Villa, Eugenio ;
Ciceri, Fabio ;
Ferreri, Andres J. M. .
EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (08) :1263-1276
[4]   Primary Central Nervous System Post-Transplantation Lymphoproliferative Disorder An International Primary Central Nervous System Lymphoma Collaborative Group Report [J].
Cavaliere, Robert ;
Petroni, Gina ;
Lopes, Maria B. ;
Schiff, David .
CANCER, 2010, 116 (04) :863-870
[5]   Management of Immunocompetent Patients With Primary Central Nervous System Lymphoma [J].
Chimienti, Emanuela ;
Spina, Michele ;
Vaccher, Emanuela ;
Tirelli, Umberto .
CLINICAL LYMPHOMA & MYELOMA, 2009, 9 (05) :353-364
[6]  
Commins Deborah L, 2006, Neurosurg Focus, V21, pE2
[7]  
Corn BW, 1997, CANCER, V79, P2409
[8]   Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome [J].
Cote, TR ;
Manns, A ;
Hardy, CR ;
Yellin, FJ ;
Hartge, P ;
Lemp, G ;
West, D ;
Singleton, J ;
Young, J ;
Kerndt, P ;
Deapen, D ;
Ginzberg, M ;
AntonCulver, H ;
Lieb, S ;
Hopkins, R ;
Williams, B ;
Liff, J ;
Morgan, D ;
Parkin, W .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (10) :675-679
[9]   Treatment of primary central nervous system lymphoma [J].
DeAngelis, LM ;
Hormigo, A .
SEMINARS IN ONCOLOGY, 2004, 31 (05) :684-692
[10]   Therapeutic management of primary central nervous system lymphoma: Lessons from prospective trials [J].
Ferreri, AJM ;
Reni, M ;
Villa, E .
ANNALS OF ONCOLOGY, 2000, 11 (08) :927-937